Celexa News

Researchers Seek Retraction of MD-18 Celexa Study

Feb. 23, 2018 – Los Angeles, California – A group of researchers sent a letter this week to Dr. Robert Freedman, Editor of the American Journal of Psychiatry, calling for the retraction of a Celexa study the researchers claim is rife with “serious misrepresentations.” The study, known as the MD-18 ‘Wagner’ [...]

Baum Hedlund Urges DOJ to Reopen Investigation re Celexa / Lexapro Clinical Trials

Boston, Massachusetts – February 8, 2018 - - The law firm of Baum, Hedlund, Aristei & Goldman has sent a letter and memorandum to the U.S. Attorney’s Office (USAO) for the District of Massachusetts calling for the reopening of its investigation and prosecution of Forest Laboratories Inc. and its subsidiary, [...]

Celexa, Lexapro and the Death of Evidence-Based Medicine

“Oh, what a tangled web we weave. When first we practise to deceive!” From Walter Scott’s epic poem, Marmion This is the story of a drug and an idea, and how, in 2004, the rise of one helped bring about the downfall of the other. The drug is Celexa (generic [...]

Settlement of Missouri Celexa® and Lexapro® Class Action Lawsuit Announced

March 26, 2014 - - Plaintiffs’ attorneys in a class action involving Forest Laboratories, Inc. and Forest Pharmaceuticals, Inc. (collectively, “Forest”) announced that they have reached a settlement of claims relating to the past marketing of the antidepressants Celexa® and Lexapro® for use by minors in Missouri.  A settlement fund ranging [...]

Federal Judge Certifies Celexa / Lexapro Pediatric Antidepressant Class Action

A federal judge has certified a class action lawsuit filed by two mothers from Missouri alleging that Forest Pharmaceuticals, Inc. and Forest Laboratories, Inc. “misrepresented and concealed” information concerning the effectiveness of two company drugs for the treatment of depression in pediatric patients. The plaintiffs, represented by the law firms Baum, [...]

Forest Pharmaceuticals Can’t Stop Missouri Pediatric Antidepressant Class Action

January 10, 2014 -- A Massachusetts federal judge has certified a class action lawsuit filed by two Missouri mothers who accuse Forest Pharmaceuticals, Inc. of "misrepresenting and concealing" information regarding the effectiveness of two company drugs prescribed to treat depression in pediatric patients.  The mothers, who are represented by the law [...]

British Drug Agency will Recommend Against Antidepressants for Pregnant Women

BBC News announced today that Britain’s National Institute for Health and Care Excellence (NICE) will soon recommend that pregnant women with mild to moderate depression avoid taking antidepressants. NICE publishes guidelines that form the basis of health care treatment in Britain and Wales. According to Professor Stephen Pilling, a NICE [...]

By | 2016-10-17T11:53:13+00:00 June 23rd, 2013|Celexa News, Pharma News|

CEO of Forest Labs Announces Retirement Two Weeks After Receiving Subpeona

Howard Solomon, the 85-year-old CEO of Forest Laboratories, has announced that he will step down from his post at the end of the year. The announcement came a little over two weeks after the U.S. Department of Justice handed Forest a subpoena concerning the drugmaker's Turdorza Pressair medication, used to treat [...]

By | 2016-10-17T11:53:20+00:00 May 23rd, 2013|Celexa News, Lexapro News, Pharma News|